Indirect pathological indicators for cardiac sarcoidosis on endomyocardial biopsy
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: The definitive pathologic diagnosis of cardiac sarcoidosis requires observation of a granuloma in the myocardial tissue. It is common, however, to receive a “negative” report for a clinically probable case. We would like to advise pathologists and clinicians on how to interpret “negative” biopsies. Methods: Our study samples were 27 endomyocardial biopsies from 25 patients, three cardiac transplantation and an autopsied heart with suspected cardiac sarcoidosis. Pathologic, radiologic, and clinical features were compared. Results: The presence of micro-granulomas or increased histiocytic infiltration was always (6/6 or 100%) associated with fatty infiltration and confluent fibrosis, and they showed radiological features of sarcoidosis. Three of five cases (60%) with fatty change and confluent fibrosis were probable for cardiac sarcoidosis on radiology. When either confluent fibrosis or fatty change was present, one-third (3/9) were radiologically probable for cardiac sarcoidosis. We interpreted cases with micro-granuloma as positive for cardiac sarcoidosis (five of 25, 20%). Cases with both confluent fibrosis and fatty change were interpreted as probable for cardiac sarcoidosis (seven of 25, 28%). Another 13 cases, including eight cases with either confluent fibrosis or fatty change, were interpreted as low probability based on endomyocardial biopsy. Conclusions: The presence of micro-granuloma could be an evidence for positive diagnosis of cardiac sarcoidosis. Presence of both confluent fibrosis and fatty change is necessary for probable cardiac sarcoidosis in the absence of granuloma. Either of confluent fibrosis or fatty change may be an indirect pathological evidence but they are interpreted as nonspecific findings.
Abstract
Background: The definitive pathologic diagnosis of cardiac sarcoidosis requires observation of a granuloma in the myocardial tissue. It is common, however, to receive a “negative” report for a clinically probable case. We would like to advise pathologists and clinicians on how to interpret “negative” biopsies. Methods: Our study samples were 27 endomyocardial biopsies from 25 patients, three cardiac transplantation and an autopsied heart with suspected cardiac sarcoidosis. Pathologic, radiologic, and clinical features were compared. Results: The presence of micro-granulomas or increased histiocytic infiltration was always (6/6 or 100%) associated with fatty infiltration and confluent fibrosis, and they showed radiological features of sarcoidosis. Three of five cases (60%) with fatty change and confluent fibrosis were probable for cardiac sarcoidosis on radiology. When either confluent fibrosis or fatty change was present, one-third (3/9) were radiologically probable for cardiac sarcoidosis. We interpreted cases with micro-granuloma as positive for cardiac sarcoidosis (five of 25, 20%). Cases with both confluent fibrosis and fatty change were interpreted as probable for cardiac sarcoidosis (seven of 25, 28%). Another 13 cases, including eight cases with either confluent fibrosis or fatty change, were interpreted as low probability based on endomyocardial biopsy. Conclusions: The presence of micro-granuloma could be an evidence for positive diagnosis of cardiac sarcoidosis. Presence of both confluent fibrosis and fatty change is necessary for probable cardiac sarcoidosis in the absence of granuloma. Either of confluent fibrosis or fatty change may be an indirect pathological evidence but they are interpreted as nonspecific findings.
참고문헌 (42)
- Lagana SM, "Cardiac sarcoidosis : a pathology-focused review", Arch Pathol Lab Med, 134, pp.1039~1046 (2010)
- Hamzeh N, "Pathophysiology and clinical management of cardiac sarcoidosis", Nat Rev Cardiol, 12, pp.278~288 (2015)
- Hulten E, "Cardiac sarcoidosis-state of the art review", Cardiovasc Diagn Ther, 6, pp.50~63 (2016)
- Newman LS, "Sarcoidosis", N Engl J Med, 336, pp.1224~1234 (1997)
- 강은해, "의학강좌", 우리나라 사르코이드증의 재조명, 2008, pp.51(10), 925~932[DOI]
- Mehta D, "Cardiac involvement in patients with sarcoidosis : diagnostic and prognostic value of outpatient testing", Chest, 133, pp.1426~1435 (2008)
- Longcope WT, "A study of sarcoidosis; based on a combined investigation of 160 cases including 30 autopsies from The Johns Hopkins Hospital and Massachusetts General Hospital", Medicine (Baltimore), 31, pp.1~132 (1952)
- Silverman KJ, "Cardiac sarcoid : a clinicopathologic study of 84 unselected patients with systemic sarcoidosis", Circulation, 58, pp.1204~1211 (1978)
- Iwai K, "Pathological studies on sarcoidosis autopsy. II. Early change, mode of progression and death pattern", Acta Pathol Jpn, 43, pp.377~385 (1993)
- Sayah DM, "Cardiac involvement in sarcoidosis : evolving concepts in diagnosis and treatment", Semin Respir Crit Care Med, 38, pp.477~498 (2017)
- Chapelon-Abric C, "Cardiac sarcoidosis:a retrospective study of 41 cases", Medicine(Baltimore), 83, pp.315~334 (2004)
- Birnie DH, "HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis", Heart Rhythm, 11, pp.1305~1323 (2014)
- Cooper LT, "The role of endomyocardial biopsy in the management of cardiovascular disease : a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology", Eur Heart J, 28, pp.3076~3093 (2007)
- Hiraga H, "Diagnostic standard and guidelines for sarcoidosis", Jpn J Sarcoidosis Granulomatous Disord, 27, pp.89~102 (2007)
- Bhimaraj A, "Robotically guided left ventricular biopsy to diagnose cardiac sarcoidosis : a multidisciplinary innovation leading to first-in-human case", Circ Heart Fail, 11, pp.e004627~ (2018)
- Liang JJ, "Electrogram guidance : a method to increase the precision and diagnostic yield of endomyocardial biopsy for suspected cardiac sarcoidosis and myocarditis", JACC Heart Fail, 2, pp.466~473 (2014)
- Casella M, "Electroanatomical mapping systems and intracardiac echo integration for guided endomyocardial biopsy", Expert Rev Med Devices, 14, pp.609~619 (2017)
- Roberts WC, "Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11)", Am J Med, 63, pp.86~108 (1977)
- 이수경, "심장사르코이드증에 의한 급사: 1예 보고", Journal of Pathology and Translational Medicine, 37(5), pp.358~361 (2003), 대한병리학회
- Asakawa N, "Immunohistochemical identification of Propionibacterium acnes in granuloma and inflammatory cells of myocardial tissues obtained from cardiac sarcoidosis patients", PLoS One, 12, pp.e0179980~ (2017)
- Fang C, "Immunological evidence for the role of mycobacteria in sarcoidosis : a meta-analysis", PLoS One, 11, pp.e0154716~ (2016)
- Ratner SJ, "Utility of endomyocardial biopsy in the diagnosis of cardiac sarcoidosis", Chest, 90, pp.528~533 (1986)
- Yodogawa K, "Effect of corticosteroid therapy on ventricular arrhythmias in patients with cardiac sarcoidosis", Ann Noninvasive Electrocardiol, 16, pp.140~147 (2011)
- Bagwan IN, "Cardiac sarcoidosis and sudden death : the heart may look normal or mimic other cardiomyopathies", Virchows Arch, 458, pp.671~678 (2011)
- Matsui Y, "Clinicopathological study of fatal myocardial sarcoidosis", Ann N Y Acad Sci, 278, pp.455~469 (1976)
- Segen JC, "The dictionary of modern medicine" (2011), Farlex Inc
- Rotterdam H, "Microgranulomas in grossly normal rectal mucosa in Crohn’s disease", Am J Clin Pathol, 67, pp.550~554 (1977)
- Nakayama T, "Clinical impact of the presence of macrophages in endomyocardial biopsies of patients with dilated cardiomyopathy", Eur J Heart Fail, 19, pp.490~498 (2017)
- Sullivan RD, "Local injection of hydrocortisone and cortisone into skin lesions of sarcoidosis", J Am Med Assoc, 152, pp.308~312 (1953)
- Sharma OP, "Pulmonary sarcoidosis and corticosteroids", Am Rev Respir Dis, 147(6 Pt 1), pp.1598~1600 (1993)
- 김민석, "Review of Sarcoidosis in a Province of South Korea from 1996 to 2014", Tuberculosis and Respiratory Diseases, 80(3), pp.291~295 (2017), 대한결핵및호흡기학회
- de Jong S, "Fibrosis and cardiac arrhythmias", J Cardiovasc Pharmacol, 57, pp.630~638 (2011)
- Terasaki F, "Cardiac sarcoidosis and arrhythmogenic right ventricular cardiomyopathy : potential differential diagnoses for arrhythmogenic ventricular cardiomyopathy", Intern Med, 55, pp.1041~1042 (2016)
- Marcus FI, "Diagnosis of arrhythmogenic right ventricular cardiomyopathy", dysplasia : proposed modification of the task force criteria, 2010, pp.121, 1533~1541
- Ponsiglione A, "A unique association of arrhythmogenic right ventricular dysplasia and acute myocarditis, as assessed by cardiac MRI : a case report", BMC Cardiovasc Disord, 16, pp.230~ (2016)
- Tavora F, "Comparison of necropsy findings in patients with sarcoidosis dying suddenly from cardiac sarcoidosis versus dying suddenly from other causes", Am J Cardiol, 104, pp.571~577 (2009)
- Shirani J, "Subepicardial myocardial lesions", Am Heart J, 125(5 Pt 1), pp.1346~1352 (1993)
- Yang Y, "Correlation of late gadolinium enhancement MRI and quantitative T2 measurement in cardiac sarcoidosis", J Magn Reson Imaging, 39, pp.609~616 (2014)
- Shimada T, "Diagnosis of cardiac sarcoidosis and evaluation of the effects of steroid therapy by gadolinium-DTPA-enhanced magnetic resonance imaging", Am J Med, 110, pp.520~527 (2001)
- Smedema JP, "Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis", J Am Coll Cardiol, 45, pp.1683~1690 (2005)
- Rosen Y, "Pathology of sarcoidosis", Semin Respir Crit Care Med, 28, pp.36~52 (2007)
- 선병주, "Prevalence of Echocardiographic Features Suggesting Cardiac Sarcoidosis in Patients With Pacemaker or Implantable Cardiac Defibrillator", Korean Circulation Journal, 41(6), pp.313~320 (2011), 대한심장학회